Skip to content

A cell atlas of human pan-joint arthrofibrosis by multi-omics

A cell atlas of human pan-joint arthrofibrosis by multi-omics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096957
Enrollment
Unknown
Registered
2025-02-10
Start date
2025-02-12
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pan-joint arthrofibrosis

Interventions

Observation group:None

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Control group: 1.Patients aged 18-70 years; 2. Patients without fibrosis during joint surgery; 3. Clinical manifestations and X-ray or MRI confirmed that the patient had no fibrotic manifestations; 4.The patient agrees to participate in the research project and signs the informed consent; Joint fibrosis experimental group: 1. Patients aged 18-70 years; 2.Patients clinically diagnosed with joint fibrosis (shoulder joint, knee joint, ankle joint, etc.), patients with joint release surgery; 3.The patient agrees to participate in the research project and signs the informed consent.

Exclusion criteria

Exclusion criteria: 1.Mental and psychological abnormalities; 2. Combined with other structural injury repair operations (including multiple ligament reconstruction, meniscus transplantation, etc.); 3.Patients with infectious diseases, musculoskeletal fibrotic diseases, neuromuscular diseases, and rheumatic immune diseases; 4. Patients with decreased joint motion due to mechanical factors; 5.Patients with serious primary cardiovascular diseases, lung diseases, endocrine and metabolic diseases, or serious diseases affecting their survival, such as tumor or AIDS, are considered not suitable for admission; 6.Patients with other acute and chronic diseases that researchers consider inappropriate for surgery;

Design outcomes

Primary

MeasureTime frame
Spatial transcriptome analysis results;

Secondary

MeasureTime frame
Histological findings;Single cell sequencing results;

Countries

China

Contacts

Public ContactJiang jia

Shanghai Sixth People's Hospital

jessicajj19@sjtu.edu.cn+86 135 2464 0386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026